GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

251 papers

Active filtersClassification:Core

Showing 97-108 of total 251 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

The Effect of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors Alone and in Combination on AF Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation.

Ramadan A; Doma M; Yazdanpanah MH; Naeem F; Ptaszek LM; Ruskin JN

Jan 1, 2026Heart rhythm

2026PubMedDirectly related

Effectiveness of telehealth versus in-person appointments for the treatment of obesity in a Brazilian public tertiary care center: A randomized controlled trial.

Rocha FRS; Ferreira RS; Janovsky CCPS; Sañudo A; Zanella MT; Carneiro G

Jan 1, 2026Journal of telemedicine and telecare

2026PubMedDirectly related

Semaglutide as adjunct treatment for obesity in adolescents receiving antipsychotic medication (the GOAL trial): protocol for a single-arm, open-label feasibility study.

Giraldi LV; Andersen JT; Jespersen J; Baden CS; Fonvig CE; Riis T; Dalhoff KP; Holm JC; Fink-Jensen A; Pagsberg AK; Christensen MB; Gade C

Jan 1, 2026BMJ open

2026PubMedDirectly related

Hidden Malnutrition in the GLP-1 Era: Micronutrient Status, Protein Adequacy, and Lean Mass as Emerging Nutritional Considerations-A Narrative Review.

Sorić T; Sarić A; Ivanišin A; Lovrić M; Milić M; Matovinović M; Matek Sarić M

Jan 1, 2026Nutrients

2026PubMedDirectly related

Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success.

Mallardo M; Messina A; Monda V; La Marra M; Monda A; Allocca S; Casillo M; Di Maio G; Perrone P; Daniele A; Monda M; Messina G; Moscatelli F; Polito R

Jan 1, 2026Nutrients

2026PubMedDirectly related

Beyond Weight Loss: Thromboinflammation as a Candidate Mechanism for the Cardiovascular Benefit of GLP-1 Receptor Agonists.

Melnikov I; Borodko D; Alekseev V

Jan 1, 2026Cells

2026PubMedDirectly related

The Impact of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists on Body Composition in Individuals with Overweight and Obesity: A Systematic Review and Meta-Analysis.

Woźniak M; Tarcz Z; Pyczek G; Bogacka J; Diniejko A; Kuryłowicz A; Mamcarz A; Śliż D

Jan 1, 2026Journal of clinical medicine

2026PubMedDirectly related

Comparative change in HbA1c and weight outcomes between obese and non-obese adults with type 2 diabetes mellitus treated with SGLT-2 inhibitors or GLP-1 receptor agonists.

Almohammed OA; Alshaya OA; Alduhayshi LA; Alshaibani ST; Alhamed MS; Alzeer MA; Alabdullah OM; Ibn Saqyan MF; Al Yami MS; Bin Sheraim N; Almohareb SN; Alfayez OM; Korayem GB

Jan 1, 2026Frontiers in endocrinology

2026PubMedDirectly related

Glucagon-like peptide-1 receptor agonists and tirzepatide are associated with reduced mortality, cardiovascular, and psychiatric risks in patients with hidradenitis suppurativa and type 2 diabetes and/or obesity: a retrospective cohort study.

Brouer IC; Zani A; Olbrich H; Ludwig RJ; Thaçi D

Jan 1, 2026Frontiers in medicine

2026PubMedDirectly related

GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction.

Reitz J; Rosoff DB; Pacher P; Lohoff FW

Jan 1, 2026Biological psychiatry global open science

2026PubMedDirectly related

Computable longitudinal patient journeys from structured and unstructured EHR data.

Kim E; Foty R; Thakor AS; Skyler JS; Robinson LF; Park JD; Kraft M; Cairns CB; Seyfert-Margolis V

Jan 1, 2026Nature medicine

2026PubMedDirectly related

Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.

Keshen A; Koning E; Allison KC; Amaro A; Bartel S; Belliveau P; Boniferro L; Brar S; Butalia S; Bulik CM; Chao AM; Couturier J; Dennis K; Dixon L; El-Ziftawi D; Gao C; Gamberg S; Goldstone AP; Dalle Grave R; Guerdjikova AI; Halliday TM; Hahn M; Harris A; Himmerich H; Horton WB; Jericho M; Langman B; Lightbody A; Klein DA; Mayer LES; McElroy SL; Mindrum M; Peiper NC; Price C; Raffoul A; Richards J; Schaefer LM; Steinglass J; Taylor VH; Tchang BG; Trappenberg N; Walsh BT; Weintraub MA; White A; Wnuk S

Jan 1, 2026World psychiatry : official journal of the World Psychiatric Association (WPA)